{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T02:15:20Z","timestamp":1775960120819,"version":"3.50.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Dalian Municipal Paramount","award":["2023DF001"],"award-info":[{"award-number":["2023DF001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"DOI":"10.1093\/ndt\/gfaf241","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:20:05Z","timestamp":1762435205000},"page":"380-383","source":"Crossref","is-referenced-by-count":1,"title":["Obinutuzumab monotherapy is effective in adult patients with nephrotic syndrome and minimal change lesions"],"prefix":"10.1093","volume":"41","author":[{"given":"Xiaolang","family":"Wang","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Dalian Medical University Department of Pediatrics, , Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingying","family":"Zhou","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Dalian Medical University, Renal Translational Medicine Center of Liaoning Province Department of Nephrology, , Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiting","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Dalian Medical University, Renal Translational Medicine Center of Liaoning Province Department of Nephrology, , Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyu","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Dalian Medical University, Renal Translational Medicine Center of Liaoning Province Department of Nephrology, , Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinwei","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Dalian Medical University, Renal Translational Medicine Center of Liaoning Province Department of Nephrology, , Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenjie","family":"Gu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Dalian Medical University, Renal Translational Medicine Center of Liaoning Province Department of Nephrology, , Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Kang","sequence":"additional","affiliation":[{"name":"Medical College of Dalian University Department of Physiology and Pathophysiology, , Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Fang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Dalian Medical University, Renal Translational Medicine Center of Liaoning Province Department of Nephrology, , Dalian ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2026013001373612300_bib1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/J.Kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"2026013001373612300_bib2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults","volume":"24","author":"Hogan","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026013001373612300_bib3","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ekir.2023.02.1070","article-title":"Rituximab as initial therapy in adult patients with minimal change disease","volume":"8","author":"Guan","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2026013001373612300_bib4","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/ndt\/gfaa133","article-title":"Comparison of treatment options in adults with frequently relapsing or steroid-dependent minimal change disease","volume":"36","author":"Heybeli","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026013001373612300_bib5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2215\/CJN.0000000000000288","article-title":"Obinutuzumab in frequently relapsing and steroid-dependent nephrotic syndrome in children","volume":"18","author":"Dossier","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026013001373612300_bib6","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/ndt\/gfae061","article-title":"Obinutuzumab is effective for the treatment of frequently-relapsing\/steroid-dependent minimal change disease in adults","volume":"39","author":"Jin","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026013001373612300_bib7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"2026013001373612300_bib8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/bjh.15232","article-title":"A tale of two antibodies: obinutuzumab versus rituximab","volume":"182","author":"Freeman","year":"2018","journal-title":"Br J Haematol"},{"key":"2026013001373612300_bib9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ekir.2024.12.012","article-title":"Obinutuzumab and ofatumumab are more effective than rituximab in the treatment of membranous nephropathy patients with anti-rituximab antibodies","volume":"10","author":"Teisseyre","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026013001373612300_bib10","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/ndt\/gfu209","article-title":"Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance","volume":"29","author":"Guitard","year":"2014","journal-title":"Nephrol Dial Transplant"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf241\/65241430\/gfaf241.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/2\/380\/65241430\/gfaf241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/2\/380\/65241430\/gfaf241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:37:41Z","timestamp":1769755061000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/2\/380\/8316851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,7]]},"published-print":{"date-parts":[[2026,1,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf241","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,11,7]]}}}